• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[口腔癌手术患者中一种特殊形式的贫血]

[A peculiar form of anemia in patients operated on for cancer of the oral cavity].

作者信息

Daniele E, Foti G

机构信息

Servizio di Medicina Generale, Ospedale G. Eastman, Roma.

出版信息

Minerva Stomatol. 1997 Dec;46(12):665-9.

PMID:9567616
Abstract

The authors related about a peculiar form of anemia found in some patients operated on oral cancer; these patients had an almost normal hematic situation before their operation. 63 patients, operated in the course of a year for oral cancer, have been studied by the authors; they have found in 14 cases (22.2%) a light anemia which regressed after a self blood transfusion, during the first week after the operation; in other 8 cases (12.7%) the anemia, which was more serious, persisted beyond the 7th day after the operation. Those 8 patients, suffering from more serious and persistent anemia, were treated from 7th to 21st day after the operation with iron, vitamin B12 and folic acid without any improvement. The hematic situation improved about 10 days after the end of treatment, probably as a result of spontaneous renewal of medullar haemopoietic activity. This anemia, is characterized by normochromia, normocytosis, reduced response of reticulocytes, sideropenia and hyperferritinaemia. The authors think that the pathogenesis of anemia after operation in neoplastic patients is caused by medullary insufficiency existing before the operation, connected with reduced erythropoietin production and emphasized by an operation that sometimes cause bleeding. Consequently the authors hypothesis the use of erythropoietin in the therapy of most severe anemia in neoplastic operated patients.

摘要

作者讲述了在一些接受口腔癌手术的患者中发现的一种特殊形式的贫血;这些患者在手术前血液状况几乎正常。作者对63例在一年内接受口腔癌手术的患者进行了研究;他们发现14例(22.2%)有轻度贫血,在术后第一周自体输血后贫血消退;另外8例(12.7%)贫血较为严重,在术后第7天之后仍持续存在。那8例患有更严重且持续贫血的患者在术后第7天至21天接受了铁、维生素B12和叶酸治疗,但没有任何改善。治疗结束约10天后血液状况有所改善,可能是由于骨髓造血活动自发恢复。这种贫血的特征是正色素性、正常红细胞性、网织红细胞反应降低、缺铁和高铁蛋白血症。作者认为肿瘤患者术后贫血的发病机制是术前存在的骨髓功能不全,与促红细胞生成素生成减少有关,且手术有时导致出血会加重这种情况。因此,作者推测在接受手术的肿瘤患者最严重贫血的治疗中使用促红细胞生成素。

相似文献

1
[A peculiar form of anemia in patients operated on for cancer of the oral cavity].[口腔癌手术患者中一种特殊形式的贫血]
Minerva Stomatol. 1997 Dec;46(12):665-9.
2
Erythropoietin and chronic lymphocytic leukemia.促红细胞生成素与慢性淋巴细胞白血病
Rev Clin Exp Hematol. 2002;Suppl 1:21-31.
3
[Psychiatric manifestations of vitamin B12 deficiency: a case report].[维生素B12缺乏的精神症状:一例报告]
Encephale. 2003 Nov-Dec;29(6):560-5.
4
Anemia of chronic disease and defective erythropoietin production in patients with celiac disease.乳糜泻患者的慢性病贫血及促红细胞生成素生成缺陷
Haematologica. 2008 Dec;93(12):1785-91. doi: 10.3324/haematol.13255. Epub 2008 Sep 24.
5
Anemia in the critically ill.危重症患者的贫血
Crit Care Clin. 2004 Apr;20(2):159-78. doi: 10.1016/j.ccc.2004.01.002.
6
[The effect of recombinant human erythropoietin on postoperative anemia in orthognathic patients].
Shanghai Kou Qiang Yi Xue. 2004 Aug;13(4):249-51.
7
[Causes of anemia after kidney transplantation].
Srp Arh Celok Lek. 1994 Sep-Oct;122(9-10):276-80.
8
Role of erythropoietin in anemia after heart transplantation.促红细胞生成素在心脏移植后贫血中的作用。
Int J Cardiol. 2006 Oct 10;112(3):341-7. doi: 10.1016/j.ijcard.2005.10.007. Epub 2005 Nov 23.
9
Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.促红细胞生成素可改善心力衰竭合并贫血患者的贫血、运动耐量及肾功能,并降低B型利钠肽水平及住院率。
Am Heart J. 2006 Dec;152(6):1096.e9-15. doi: 10.1016/j.ahj.2006.08.005.
10
Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.癌症相关性贫血患者对重组人促红细胞生成素治疗反应的预测
Med Oncol. 1998 Aug;15 Suppl 1:S38-46.